Literature DB >> 8018397

Factors associated with bacteraemia in febrile, granulocytopenic cancer patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC).

C Viscoli1, P Bruzzi, E Castagnola, L Boni, T Calandra, H Gaya, F Meunier, R Feld, S Zinner, J Klastersky.   

Abstract

The objective of this investigation was to determine factors predictive of bacteraemia at presentation in febrile, granulocytopenic cancer patients in order to estimate the probability of bacteraemia in each patient, and to compare factors associated with a diagnosis of gram-positive or gram-negative bacteraemia. Retrospective analysis of two sets of data (derivation and validation sets) randomly obtained from a large prospective study was conducted in a multicentre study of febrile, granulocytopenic cancer patients admitted for empiric antibacterial therapy. Within the derivation set, prognostic factors (clinical and laboratory data) likely to be associated with a generic diagnosis of bacteraemia and with a specific diagnosis of gram-positive or gram-negative bacteraemia were analysed by means of three backward, stepwise, logistic regression analyses. The predictive probability of bacteraemia was calculated using the logistic equation. The discriminating ability of the model in predicting bacteraemia was evaluated in the derivation and validation sets using receiver-operating characteristic curves. The predictive probability of gram-positive or gram-negative bacteraemia was not calculated. In the derivation set, 157 of 558 episodes (28%) were microbiologically documented bacteraemias. Predicting factors were antifungal prophylaxis, duration of granulocytopenia before fever, platelet count, highest fever, shock and presence and location of initial signs of infection. The variables institution, antibacterial prophylaxis and underlying disease showed borderline associations with bacteraemia. Shock was associated with gram-negative bacteraemia, while signs of infection at catheter site were predictive of gram-positive bacteraemia. Quinolone prophylaxis was negatively associated with gram-negative bacteraemia. When tested in the validation set, the model was poorly predictive, although a small subgroup of episodes (representing only 16% of the total sample size) with low risk of bacteraemia was identified. Factors predictive of bacteraemia can be identified, with discrimination between gram-positive and gram-negative aetiology. Further studies are warranted in order to improve the discriminant ability of the model.

Entities:  

Mesh:

Year:  1994        PMID: 8018397     DOI: 10.1016/0959-8049(94)90412-x

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  26 in total

1.  Staphylococcus aureus, Platelets, and the Heart.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

2.  Purification and in vitro activities of rabbit platelet microbicidal proteins.

Authors:  M R Yeaman; Y Q Tang; A J Shen; A S Bayer; M E Selsted
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

Review 3.  The Microbiota in Hematologic Malignancies.

Authors:  Yajing Song; Bryan Himmel; Lars Öhrmalm; Peter Gyarmati
Journal:  Curr Treat Options Oncol       Date:  2020-01-11

4.  Predicting febrile neutropenic patients at low risk using the MASCC score: does bacteremia matter?

Authors:  Marianne Paesmans; Jean Klastersky; Johan Maertens; Aspasia Georgala; Frédérique Muanza; Mickael Aoun; Augustin Ferrant; Bernardo Rapoport; Ken Rolston; Lieveke Ameye
Journal:  Support Care Cancer       Date:  2010-07-02       Impact factor: 3.603

Review 5.  Outpatient therapy for febrile neutropenia: clinical and economic implications.

Authors:  Fausto de Lalla
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

6.  European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia.

Authors:  Diana Averbuch; Christina Orasch; Catherine Cordonnier; David M Livermore; Malgorzata Mikulska; Claudio Viscoli; Inge C Gyssens; Winfried V Kern; Galina Klyasova; Oscar Marchetti; Dan Engelhard; Murat Akova
Journal:  Haematologica       Date:  2013-12       Impact factor: 9.941

7.  An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients.

Authors:  A Engel; E Mack; P Kern; W V Kern
Journal:  Infection       Date:  1998 Jul-Aug       Impact factor: 3.553

8.  Platelet antistaphylococcal responses occur through P2X1 and P2Y12 receptor-induced activation and kinocidin release.

Authors:  Darin A Trier; Kimberly D Gank; Deborah Kupferwasser; Nannette Y Yount; William J French; Alan D Michelson; Leon I Kupferwasser; Yan Q Xiong; Arnold S Bayer; Michael R Yeaman
Journal:  Infect Immun       Date:  2008-09-29       Impact factor: 3.441

9.  Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice.

Authors:  Helen Innes; Sheow Lei Lim; Allison Hall; Su Yin Chan; Neeraj Bhalla; Ernest Marshall
Journal:  Support Care Cancer       Date:  2007-09-25       Impact factor: 3.603

10.  Predicting the complicated neutropenic fever in the emergency department.

Authors:  J M Moon; B J Chun
Journal:  Emerg Med J       Date:  2009-11       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.